Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor

Clinical trial NCT01096381 · TERMINATED

Trial details

NCT number: NCT01096381
Sponsor: Vanderbilt-Ingram Cancer Center
Status: TERMINATED
Study type: OBSERVATIONAL

Breast Cancer Cardiovascular Complications Colorectal Cancer Fallopian Tube Cancer Head and Neck Cancer Lung Cancer Ovarian Cancer Peritoneal Cavity Cancer Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2010-03-01
Primary completion: 2011-07-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.